Warfarin is connected with Aspirin and Antithrombotic in his research. He performs multidisciplinary study on Aspirin and Warfarin in his works. His work in Antithrombotic is not limited to one particular discipline; it also encompasses Cardiology. Cardiology connects with themes related to Ischemic stroke in his study. His Stroke (engine) study frequently draws connections to other fields, such as Mechanical engineering. Gregory W. Albers regularly ties together related areas like Stroke (engine) in his Mechanical engineering studies. He undertakes multidisciplinary studies into Magnetic resonance imaging and Hyperintensity in his work. He regularly links together related areas like Internal carotid artery in his Radiology studies. His study brings together the fields of Radiology and Internal carotid artery.
Within the field of Diffusion MRI and Effective diffusion coefficient Gregory W. Albers studies Magnetic resonance imaging. His Pathology study frequently draws connections between adjacent fields such as Alternative medicine and Lesion. He frequently studies issues relating to Pathology and Alternative medicine. With his scientific publications, his incorporates both Lesion and Magnetic resonance imaging. His work on Mechanical engineering expands to the thematically related Stroke (engine). Mechanical engineering is often connected to Stroke (engine) in his work. Much of his study explores Internal medicine relationship to Confidence interval. His Confidence interval study often links to related topics such as Internal medicine. His Cardiology study often links to related topics such as Embolism.
Internal medicine connects with themes related to Transcranial Doppler in his study. His Internal medicine research extends to Transcranial Doppler, which is thematically connected. His Mechanical engineering research extends to Stroke (engine), which is thematically connected. His Mechanical engineering study frequently involves adjacent topics like Stroke (engine). Gregory W. Albers combines Randomized controlled trial and Clinical endpoint in his studies. Gregory W. Albers performs multidisciplinary study in the fields of Clinical endpoint and Randomized controlled trial via his papers. He conducts interdisciplinary study in the fields of Clinical trial and Randomization through his research. He integrates Randomization and Clinical trial in his research. Gregory W. Albers carries out multidisciplinary research, doing studies in Ischemia and Reperfusion therapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke
Jeffrey L. Saver;Mayank Goyal;Alain Bonafe;Hans Christoph Diener.
The New England Journal of Medicine (2015)
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials
Werner Hacke;Geoffrey Donnan;Cesare Fieschi;Markku Kaste.
The Lancet (2004)
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
Gregory W. Albers;Michael P. Marks;Stephanie Kemp;Soren Christensen.
The New England Journal of Medicine (2018)
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Kennedy R Lees;Erich Bluhmki;Rüdiger von Kummer;Thomas G Brott.
The Lancet (2010)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson;Kennedy R Lees;Patrick Lyden;Lisa Blackwell.
The Lancet (2014)
Definition and evaluation of transient ischemic attack: A scientific statement for healthcare professionals from the American heart association/American stroke association stroke council; council on cardiovascular surgery and anesthesia; council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease
J. Donald Easton;Jeffrey L. Saver;Gregory W. Albers;Mark J. Alberts.
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Karen L. Furie;Scott E. Kasner;Robert J. Adams;Gregory W. Albers.
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Wayne M. Clark;Stanley Wissman;Gregory W. Albers;Jack H. Jhamandas.
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
J.P. Mohr;J.L.P. Thompson;Ronald M. Lazar;Bruce Levin.
The New England Journal of Medicine (2001)
Transient Ischemic Attack — Proposal for a New Definition
Gregory W. Albers;Louis R. Caplan;J. Donald Easton;Pierre B. Fayad.
The New England Journal of Medicine (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: